Can immune parameters be used as predictors to distinguish between pulmonary multidrug-resistant and drug-sensitive tuberculosis?

Archives of Medical Science

Volumn 6, Issue 1, 2010, Pages 77-82

  Kiran, Bayram ^a   Cagatay, Tulin ^a   Clark, Philip ^b   Kosar, Filiz ^c   Cagatay, Penbe ^d   Yurt, Sibel ^c   Suzergoz, Faruk ^e   Gurol, Ali Osman ^d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c Yedikule Teaching Hospital   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e HARRAN UNIVERSITY   (Turkey)

Author keywords

T cell; HLA DR; Multidrug resistant tuberculosis; NK T cell

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; FAS ANTIGEN; HLA DR3 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NATURAL KILLER T CELL;

EID: 77949418854     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.13511     Document Type: Article

References (28)

1. Blöndal K. Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bull World Health Organ 2007; 85: 387-90.
2. Uffredi ML, Truffot-Pernot C, Dautzenberg B, Renard M, Jarlier V, Robert J. An intervention programme for the management of multidrug-resistant tuberculosis in France. Int J Antimicrob Agents 2007; 29: 434-9.
3. Chaudhury RR, Thatte U. Beyond DOTS: avenues ahead in the management of tuberculosis. Natl Med J India 2003; 16: 321-7.
4. Katalinić-Janković V, Obrovac M. Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis. Acta Med Croatica 2004; 58: 323-8.
5. Hu DY, Wang T, Liu XY, et al. Study on the risk factors leading to irregularly anti-pulmonary tuberculosis drug taking in patients with smear positive [Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2007; 28: 237-40.
6. Deveci F, Akbulut HH, Celik I, Muz MH, Ilhan F. Lymphocyte subpopulation in pulmonary tuberculosis patients. Mediators Inflamm 2006; 2006: 89070.
7. Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993; 167: 1481-97.
8. Rodrigues DS, Medeiros EA, Weckx LY, Bonnez W, Salomao R, Kallas EG. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clin Exp Immunol 2002; 128: 149-54.
9. Tsao TC, Chen CH, Hong JH, Hsieh MJ, Tsao KC, Lee CH. Shifsts of T4/T8 lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis. Chest 2002; 122: 1285-91.
10. Hwang CH, Khan S, Ende N, Mangura BT, Reichman LB, Chou J. The HLA-A, -B, and -DR phenotypes and tuberculosis. Am Rev Respir Dis 1985; 132: 382-5.
11. Bothamley GH, Beck JS, Schreuder GM, et al. Association of Tuberculosis and M. Tuberculosis-specific antibody levels with HLA. J Infect Dis 1989; 159: 549-55.
12. Meyer CG, May J, Stark K. Human leukocyte antigens in tuberculosis and leprosy. Trends Microbiol 1998; 6: 148-54.
13. Sharma SK, Turaga KK, Balamurugan A, et al. Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol 2003; 3: 183-8.
14. Drobniewski F, Rüsch-Gerdes S, Hoffner S. Antimicrobial susceptibility testing of Mycobacterium tuberculosis Report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Clin Microbiol Infect 2007; 13: 1144-56.
15. Newman MJ, Addo KK, Aboagye S, et al. Culture and sensitivity of mycobacterial isolates from cases of pulmonary tuberculosis classified as treatment failures in a teaching hospital. West Afr J Med 2007; 26: 131-3.
16. Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 2008; 21: 587-95.
17. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. Engl J Med 2003; 348: 119-28.
18. Yoneda T, Ellner JJ. CD4(+) T cell and natural killer cell-dependent killing of Mycobacterium tuberculosis by human monocytes. Am J Respir Crit Care Med 1998; 158: 395-403.
19. Montes Santiago J, Gambon DF, Pacheco CM, Cerda MT. Cellular immune response in tuberculosis: analysis of T lymphocytes and their subsets, B lymphocytes and natural cytotoxic cells in different tuberculosis states and body fluids. Rev Clin Esp 1996; 196: 223-7.
20. Lewinsohn DA, Winata E, Swarbrick GM, et al. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog 2007; 3: 1240-9.
21. Yildiz P, Kadakal F, Tutuncu Y, et al. Natural killer cell activity in multidrug-resistant pulmonary tuberculosis. Respiration 2001; 68: 590-4.
22. Cagatay T, Kiran B, Yurt S, Gulbaran Z, Kosar F, Cagatay P. Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multi-drug resistant tuberculosis. Respirology 2005; 10: 290-4.
23. Sibiryak SV, Yusupova RS, Kayumova EU. Fas/Apo-1 (CD95) Antigen expression on the peripheral blood lymphocytes in healthy donors and pulmonary tuberculosis patients. Russ J Immunol 1999; 4: 33-42.
24. Zahran WA, Ghonaim MM, Koura BA, El-Banna H, Ali SM, El-Sheikh N. Human natural killer T cells (NKT), NK and T cells in pulmonary tuberculosis: potential indicators for disease activity and prognosis. Egypt J Immunol 2006; 13: 67-78.
25. Behar SM, Porcelli SA. CD1-restricted T cells in host defense to infectious diseases. Curr Top Microbiol Immunol 2007; 314: 215-50.
26. Nishimura T, Kitamura H, Iwakabe K, et al. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 2000; 12: 987-94.
27. Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gamma-delta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006; 177: 4662-9.
28. Lee J, Choi K, Olin MR, Cho SN, Molitor TW. Gamma-delta T cells in immunity induced by Mycobacterium bovis bacillus Calmette-Guerin vaccination. Infect Immun 2004; 72: 1504-11.